| 產(chǎn)品標(biāo)題 |
產(chǎn)品貨號 |
產(chǎn)品規(guī)格 |
廠家 |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510299 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510300 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510301 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510334 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510335 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510336 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510337 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510338 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS510339 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511091 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511319 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511599 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511600 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511602 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511603 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511604 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Prostatic intraepithelial neoplasia from ORIGENE TECHNOLOGIES | CS511605 | 5x5um | ORIGENE TECHNOLOGIES |
| Human RNA binding motif, single stranded interacting protein (RBMS3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP320037 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA binding motif, single stranded interacting protein 1 (RBMS1), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760059 | 50 ug | ORIGENE TECHNOLOGIES |
| Human RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)) (RALY), transcript variant 1 from ORIGENE TECHNOLOGIES | TP310723 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)) (RALY), transcript variant 2 from ORIGENE TECHNOLOGIES | TP323333 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA binding protein, fox-1 homolog (C. elegans) 1 (RBFOX1), transcript variant 6, full length from ORIGENE TECHNOLOGIES | TP761105 | 50ug | ORIGENE TECHNOLOGIES |
| Human interferon induced with helicase C domain 1 (IFIH1) from ORIGENE TECHNOLOGIES | TP315661 | 20 ug | ORIGENE TECHNOLOGIES |
| RQCD1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN216067BN | 1 kit | ORIGENE TECHNOLOGIES |
| RQCD1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN216067LP | 1 kit | ORIGENE TECHNOLOGIES |
| RQCD1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN216067RB | 1 kit | ORIGENE TECHNOLOGIES |
| Human neuronal cell adhesion molecule (NRCAM), transcript variant 2 from ORIGENE TECHNOLOGIES | TP721072 | 10 ug | ORIGENE TECHNOLOGIES |
| Human neuronal guanine nucleotide exchange factor (NGEF), transcript variant 1 from ORIGENE TECHNOLOGIES | TP306775 | 20 ug | ORIGENE TECHNOLOGIES |
| SNRPC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418418 | 1 kit | ORIGENE TECHNOLOGIES |
| Snrpc - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516404 | 1 kit | ORIGENE TECHNOLOGIES |
| SNRPC Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318418 | 10 ug | ORIGENE TECHNOLOGIES |
| PTPMT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415376 | 1 kit | ORIGENE TECHNOLOGIES |
| Ptpmt1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514205 | 1 kit | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 (SLC7A2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422792 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 (SLC7A3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409930 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 (SLC7A3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420766 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 (SLC7A3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425814 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 (SLC7A6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418309 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 (SLC7A6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421365 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 (SLC7A6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425834 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418308 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426647 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426648 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (SLC7A8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402177 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (SLC7A8), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405401 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 (SLC7A9), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415397 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 (SLC7A9), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426676 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 5 (choline transporter), member 7 (SLC5A7) from ORIGENE TECHNOLOGIES | LY402880 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 35 (CMP-sialic acid transporter), member A1 (SLC35A1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401931 | 100 ug | ORIGENE TECHNOLOGIES |
| Solute carrier family 31 (copper transporters), member 2 (SLC31A2) from ORIGENE TECHNOLOGIES | LY400700 | 100 ug | ORIGENE TECHNOLOGIES |